[Prospective noninterventional BLUE SKY study evaluating the efficacy of brolucizumab in treatment-naïve and previously treated patients with neovascular AMD].
Faatz H, Feltgen N, Gutfleisch M, Heimes-Bussmann B, Krohne TU, Liakopoulos S, Liegl R, Lommatzsch A, Mussinghoff P, Rehak M, Schmitz-Valckenberg S, Spital G, Stanzel B, Ziemssen F, Hägele B, Junkes C, Porstner M, Vögeler J, Gmeiner B, Pauleikhoff D.
Faatz H, et al. Among authors: stanzel b.
Ophthalmologie. 2023 Mar;120(3):294-300. doi: 10.1007/s00347-022-01731-2. Epub 2022 Sep 20.
Ophthalmologie. 2023.
PMID: 36127450
German.